In vivo comparison of myocardial T1 with T2 and T2* in thalassaemia major

Journal of Magnetic Resonance Imaging

Volumn 38, Issue 3, 2013, Pages 588-593

  Feng, Yanqiu ^a,b   He, Taigang ^b,c   Carpenter, John Paul ^b,c   Jabbour, Andrew ^b,c   Alam, Mohammed Harith ^b,c   Gatehouse, Peter D ^b,c   Greiser, Andreas ^d   Messroghli, Daniel ^e   Firmin, David N ^b,c   Pennell, Dudley J ^b,c  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d SIEMENS AG   (Germany)

^e DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

MRI relaxometry; myocardium; T1; T2; tissue characterization

Indexed keywords

IRON CHELATING AGENT;

ADULT; ARTICLE; COMPARATIVE STUDY; FEMALE; HEART MUSCLE; HUMAN; IN VIVO STUDY; IRON CHELATION; IRON OVERLOAD; MAGNETIC FIELD; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THALASSEMIA MAJOR;

MRI RELAXOMETRY; MYOCARDIUM; T1; T2; T2*; TISSUE CHARACTERIZATION;

BETA-THALASSEMIA; CARDIOMYOPATHIES; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IRON OVERLOAD; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84883376884     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24010     Document Type: Article

References (24)

1. Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and disease complications in thalassemia major. Ann NY Acad Sci 1998; 850: 227-231.
2. Modell B, Khan M, Darlison M,. Survival in beta thalassaemia major in the UK: data from the UK Thalassaemia Register. Lancet 2000; 355: 2051-2052.
3. Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ,. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2008; 10: 42.
4. Anderson LJ, Holden S, Davies B, et al. Cardiovascular T2* (T2 star) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001; 22: 2171-2179.
5. Westwood M, Anderson LJ, Firmin DN, et al. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging 2003; 18: 33-39.
6. He T, Gatehouse PD, Kirk P, et al. Black-blood T2* technique for myocardial iron measurement in thalassemia. J Magn Reson Imaging 2007; 25: 1205-1209.
7. Carpenter JP, He T, Kirk P, et al. On T2* magnetic resonance and cardiac iron. Circulation 2011; 123: 1519-1528.
8. Tanner MA, He T, Westwood MA, Firmin DN, Pennell DJ,. Thalassemia International Federation Heart T2* Investigators. Multi-center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron. Haematologica 2006; 91: 1388-1391.
9. Kirk P, He T, Anderson LJ, et al. International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers. J Magn Reson Imaging 2010; 32: 315-319.
10. He T, Gatehouse PD, Anderson LJ, et al. Development of a novel optimized breathhold technique for myocardial T2 measurement in thalassemia. J Magn Reson Imaging 2006; 24: 580-585.
11. He T, Kirk P, Firmin DN, Lam WM, et al. Multi-center transferability of a breath-hold T2 technique for myocardial iron assessment. J Cardiovasc Magn Reson 2008; 10: 11.
12. Gillis P, Roch A, Brooks RA,. Corrected equations for susceptibility induced T2-shortening. J Magn Reson 1999; 137: 402-407.
13. He T, Smith GC, Gatehouse PD, Mohiaddin RH, Firmin DN, Pennell DJ,. On using T2 to assess extrinsic magnetic field inhomogeneity effects on T2* measurements in myocardial siderosis in thalassemia. Magn Reson Med 2009; 61: 501-506.
14. Engelhardt R, Langkowsky JH, Fischer R, et al. Liver iron quantification: studies in aqueous iron solutions, iron overloaded rats, and patients with hereditary hemochromatosis. Magn Reson Imaging 1994; 12: 999-1007.
15. Stark DD, Moseley ME, Bacon BR, et al. Magnetic resonance imaging and spectroscopy of hepatic iron overload. Radiology 1985; 154: 137-142.
16. Wood JC, Otto-Duessel M, Aguilar M, et al. Cardiac iron determines cardiac T2, T2, and T1 in the gerbil model of iron cardiomyopathy. Circulation 2005; 112: 535-543.
17. Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP,. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 2004; 52: 141-146.
18. Messroghli DR, Plein S, Higgins DM, et al. Human myocardium: single-breath-hold MR T1 mapping with high spatial resolution-reproducibility study. Radiology 2006; 238: 1004-1012.
19. He T, Zhang J, Carpenter JP, et al. Automated truncation method for myocardial T2* measurement in thalassemia. J Magn Reson Imaging 2012. [Epub ahead of print].
20. Messroghli DR, Rudolph A, Abdel-Aty H, et al. An open-source software tool for the generation of relaxation time maps in magnetic resonance imaging. BMC Med Imaging 2010; 10: 16.
21. Scheffler K., and, S. Lehnhardt, Principles and applications of balanced SSFP techniques. Eur Radiol 2003; 13: 2409-2418.
22. Abbruzzese G, Cossu G, Balocco M, Marchese R, Murgia D, Melis M, Galanello R, Barella S, Matta G, Ruffinengo U, Bonuccelli U, Forni GL,. A pilot trial of deferiprone for neurodegeneration with brain iron accumulation. Haematologica 2011; 96: 1708-1711.
23. Messroghli DR, Greiser A, Frohlich M, Dietz R, Schulz-Menger,. Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart. J Magn Reson Imaging 2007; 26: 1081-1086.
24. Pepe A, Positano V, Santarelli MF, et al. Multislice multiecho T2* cardiovascular magnetic resonance for detection of the heterogeneous distribution of myocardial iron overload. J Magn Reson Imaging 2006; 23: 662-668.